Navigation Links
ChromaDex® Announces Financial Results for the Year Ended 2011
Date:3/15/2012

845   Operating expenses:Sales and marketing2,539,252   ,085,510   General and administrative7,796,806   3,876,488   Operating expenses,336,058   4,961,998   Operating loss(7,864,239)  (2,017,153)  Nonoperating income (expenses):Interest income,397   ,545   Interest expense(32,142)  (36,068)  Nonoperating expenses(30,745)  (34,523)  Net loss $
(7,894,984)   $
(2,051,676)  Basic and Diluted loss per common share

$
(0.12)   $
(0.04)  Basic and Diluted weighted average common shares outstanding8,306,812   48,251,930   Quantitative reconciliation of the differences between the non-GAAP measure and the associated comparable GAAP measureConsolidated Statements of Operations (US GAAP)Effects of Non-cash Charges associated with Consolidated Statements of Operations Share-based Compensation ExpenseExcluding Share-based Compensation (Non-GAAP Presentation) Years Ended December 31, 2011 and January 1, 2011Years Ended December 31, 2011 and January 1, 2011Years Ended December 31, 2011 and January 1, 2201120102011201020112010Sales

$  8,112,610$  7,566,370Sales

$
-$
-Sales

$  8,112,610$  7,566,370Cost of sales

5,640,7914,621,525Cost of sales

--Cost of sales

5,640,7914,621,525Gross profit2,471,8192,944,845Gross profit--Gross profit2,471,8192,944,845Operating expenses:Operating expenses:Operating expenses:Sales and marketing

2,539,2521,085,510Sales and marketing

--Sales and marketing

2,539,2521,085,510General and administrative

7,796,8063,876,488General and administrative

(2,969,150)(1,262,071)General and administrative

4,827,6562,614,417Operating expenses10,336,0584,961,998Op
'/>"/>

SOURCE ChromaDex
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology news :

1. ChromaDex® Expands National Launch of its BluScience™ Line of Dietary Supplements Through McKesson
2. ChromaDex® Announces Management Changes
3. ChromaDex® Names Debra Heim as COO
4. NIAID announces 25 new awards to develop radiation countermeasures
5. Aware Announces Q3 2008 Earnings Conference Call
6. Governor Doyle announces historic genomic research collaboration
7. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
8. NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders
9. Parkinsons Disease Foundation announces award of $150,000
10. Jefferson Department of Surgery announces new pancreas tumor registry
11. NAS announces initiative to connect entertainment industry with top experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/12/2015)... , March 12, 2015 WHEN:Tuesday, March ... Registration here: http://bit.ly/1G7Os0L . SPEAKERS: , Frost ... SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 Biometric ... to compete in several different markets and industries. ... currently witnessing an uptrend. Join ...
(Date:3/11/2015)...   The Sync Project™ today announced ... and harness music to improve health. The platform ... measurements of physiology, enabling the study of the ... populations. It is designed for medical and health ... studies and accelerate the discovery of the clinical ...
(Date:3/10/2015)... March 10, 2015 Transforming How ... "Personalized Medicine in Human Space Flight" by ... J. Goodwin , Ph.D. was recently featured by Springer ... two years. Specifically, "Personalized Medicine in Human ... papers published in 2013 and 2014 from Springer in ...
Breaking Biology News(10 mins):Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2
... Treatment with the oral antiviral Tamiflu (oseltamivir) and ... be one of the most cost-effective strategies for ... According to modelling research presented by Beate Sander, ... sufficient to cover 65% of a country’s population ...
... serve as biofactories for the production of various beneficial ... new genes into mushrooms. , "There has always been ... choice platform for the mass production of commercially valuable ... B. Swayne Chair in spawn science and professor of ...
... causes disease have come to a simple conclusion -- ... might help them find a new treatment for what can ... genes responsible for toxin production only seem to be expressed ... with the view that most disease-causing bacteria express their pathogenicity ...
Cached Biology News:Experts predict Tamiflu could halve the pandemic influenza death toll versus no intervention 2Modified mushrooms may yield human drugs 2Understanding why C. difficile causes disease -- it's hungry 2
(Date:3/27/2015)... The consumption of compound fertilizers (NPK) fertilizers ... high prices in 2008. However, the situation has stabilised ... gaining momentum now. , To date, the world annual ... thousand tonnes. No considerable growth was registered in the ... during 2012-2013, registering 11% growth as against the period ...
(Date:3/27/2015)... Mich. , March 27, 2015  Neogen Corporation ... LLC, has adopted a prearranged trading plan in accordance ... Herbert , Chairman and CEO of Neogen Corporation, is ... of Neogen Corporation common stock. Herbert does ... disclosure was appropriate. The filing is only for a ...
(Date:3/27/2015)... March 27, 2015  Peter Walter was chosen as ... his pioneering work on how proteins are transported between ... regulatory mechanism that cells use to handle stress tied ... a professor of biochemistry at the University of California, ... a range of human diseases related to defective protein ...
(Date:3/27/2015)... , March 27, 2015 WuXi ... leading open-access R&D capability and technology platform company ... industries, announced today that an Investigational New Drug ... antibody for rheumatoid arthritis has been accepted for ... (CFDA).  In September 2012, MedImmune, ...
Breaking Biology Technology:World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 2World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 3Neogen CEO adopts 10b5-1 Trading Plan 2German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 2German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 3Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 3
... the Phase III Clinical Development and ... of THR-100 in Developing Countries, LEUVEN, Belgium, ... biotechnology company focused on vascular disease, today,announced the ... International Limited (Hyderabad, India) for the manufacture of,THR-100, ...
... Collaboration With CDC to Ensure US,s Preparedness ... Public Health Emergency, CAMBRIDGE, England and CAMBRIDGE, ... a leading,vaccine company, announced today that the US ... (Smallpox (Vaccinia) Vaccine, Live) vaccine,for protection against smallpox. ...
... Sept. 3 Leading neurosurgical device,developer Elekta ... and treatment devices, along with clinical workflow ... at the European,Association of Neurosurgical Societies (EANS) ... neurosurgeons and related medical professionals,will gather at ...
Cached Biology Technology:ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 2ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 3ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 4FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox 2FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox 3FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox 4FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox 5Elekta Demonstrates Commitment to Stereotactic Innovation at EANS 2Elekta Demonstrates Commitment to Stereotactic Innovation at EANS 3Elekta Demonstrates Commitment to Stereotactic Innovation at EANS 4
Mouse polyclonal antibody raised against a partial recombinant KCTD13. NCBI Entrez Gene ID = 253980...
... selection system for recombinant identification. Recombinant selection ... need for costly color screening. This quick ... accuracy in recombinant selection. pLivSelect is also ... This cloning kit is customized as ...
Alpha-2-antiplasmin precursor (Alpha-2-plasmin inhibitor) (Alpha-2-PI) (Alpha-2-AP). [Source:Uniprot/SWISSPROT;Acc:P08697] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Mouse monoclonal antibody raised against a partial recombinant ZNF167. NCBI Entrez Gene ID = ZNF167...
Biology Products: